These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 23225191)
41. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging. Rhee TK; Naik NK; Deng J; Atassi B; Mulcahy MF; Kulik LM; Ryu RK; Miller FH; Larson AC; Salem R; Omary RA J Vasc Interv Radiol; 2008 Aug; 19(8):1180-6. PubMed ID: 18656011 [TBL] [Abstract][Full Text] [Related]
42. Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis. Iñarrairaegui M; Thurston KG; Bilbao JI; D'Avola D; Rodriguez M; Arbizu J; Martinez-Cuesta A; Sangro B J Vasc Interv Radiol; 2010 Aug; 21(8):1205-12. PubMed ID: 20598574 [TBL] [Abstract][Full Text] [Related]
43. Yttrium-90 radioembolization of malignant tumors of the liver: gallbladder effects. Sag AA; Savin MA; Lal NR; Mehta RR AJR Am J Roentgenol; 2014 May; 202(5):1130-5. PubMed ID: 24758670 [TBL] [Abstract][Full Text] [Related]
44. Underlying liver disease influences volumetric changes in the spared hemiliver after selective internal radiation therapy with 90Y in patients with hepatocellular carcinoma. Teo JY; Goh BK; Cheah FK; Allen JC; Lo RH; Ng DC; Goh AS; Khor AY; Sim HS; Ng JJ; Chow PK J Dig Dis; 2014 Aug; 15(8):444-50. PubMed ID: 24828952 [TBL] [Abstract][Full Text] [Related]
46. Treatment of hepatocellular carcinoma by radioembolization using 90Y microspheres. Sangro B; Bilbao JI; Iñarrairaegui M; Rodriguez M; Garrastachu P; Martinez-Cuesta A Dig Dis; 2009; 27(2):164-9. PubMed ID: 19546555 [TBL] [Abstract][Full Text] [Related]
47. Safety of yttrium-90 microsphere radioembolization in patients with biliary obstruction. Gaba RC; Riaz A; Lewandowski RJ; Ibrahim SM; Ryu RK; Sato KT; Omary RA; Salem R J Vasc Interv Radiol; 2010 Aug; 21(8):1213-8. PubMed ID: 20598575 [TBL] [Abstract][Full Text] [Related]
52. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. Dancey JE; Shepherd FA; Paul K; Sniderman KW; Houle S; Gabrys J; Hendler AL; Goin JE J Nucl Med; 2000 Oct; 41(10):1673-81. PubMed ID: 11037997 [TBL] [Abstract][Full Text] [Related]
53. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy]. Tischoff I; Tannapfel A Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632 [TBL] [Abstract][Full Text] [Related]
54. State of the art: radiolabeled microspheres treatment for liver malignancies. Deleporte A; Flamen P; Hendlisz A Expert Opin Pharmacother; 2010 Mar; 11(4):579-86. PubMed ID: 20163269 [TBL] [Abstract][Full Text] [Related]
55. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis. Goin JE; Salem R; Carr BI; Dancey JE; Soulen MC; Geschwind JF; Goin K; Van Buskirk M; Thurston K J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):195-203. PubMed ID: 15713920 [TBL] [Abstract][Full Text] [Related]
56. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. Salem R; Thurston KG J Vasc Interv Radiol; 2006 Sep; 17(9):1425-39. PubMed ID: 16990462 [TBL] [Abstract][Full Text] [Related]
57. Treatment modification of yttrium-90 radioembolization based on quantitative positron emission tomography/CT imaging. Chang TT; Bourgeois AC; Balius AM; Pasciak AS J Vasc Interv Radiol; 2013 Mar; 24(3):333-7. PubMed ID: 23433408 [TBL] [Abstract][Full Text] [Related]
58. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
59. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives]. Hilgard P; Müller S; Hamami M; Sauerwein WS; Haberkorn U; Gerken G; Antoch G Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591 [TBL] [Abstract][Full Text] [Related]